Full 2L QBank
Anatomy Other topics and Adverse effects 9470fd74

dihydroerigotamine differs from ergotamine in the following respect

A
It is more potent oxytocic
B
it has antimetic propey
C
it has high oral bioavailability
D
it is more potent alpha adrenergic blocker and less potent vasoconstrictor
High-Yield Explanation
hydrogenation of ergot alkaloids decrease their vasoconstrictor action and increase the Alpha blocking activity Ref-KDT 6/e p168

Related Anatomy MCQs

Practice 2,00,000+ NEET PG Questions Free

Timed mock tests, mistake queue analytics, audio lectures & zero attempt limits on i❤️Exams.

Start Free Mock Test Now